Evidence map›Paper›PMID 34909722›Full record

ArticleJID innovations : skin science from molecules to population health2021

Two

Youssef Elhaji, Tessa M A van Henten, Claudia A L Ruivenkamp, Mathew Nightingale, Gijs We Santen, Lydia E Vos, Peter R Hull

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JID innovations : skin science from molecules to population health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Youssef ElhajiDivision of Clinical Dermatology & Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Tessa M A van HentenDepartment of Dermatology, Haaglanden Medical Center, The Hague, The Netherlands.
Claudia A L RuivenkampDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Mathew NightingaleGenomics Core facility, Dalhousie University, Halifax, Nova Scotia, Canada.
Gijs We SantenDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Lydia E VosDepartment of Dermatology, Haaglanden Medical Center, The Hague, The Netherlands.
Peter R HullDivision of Clinical Dermatology & Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Dalhousie University · CALeiden University Medical Center · NLMedisch Centrum Haaglanden · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Basan syndrome is an autosomal dominant genodermatosis characterized by congenital adermatoglyphia, transient congenital facial milia, neonatal acral bullae, and absent or reduced sweating. Basan syndrome is rare and has been reported in only 10 kindreds worldwide. It is caused by variants in the skin-specific isoform of

Indexed as

bp, base pairkb, kilobase

Identifiers

PMID34909722
PMCPMC8659716
OpenAlexW3159548302

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.